These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28661203)

  • 1. Application of NICE guideline NG12 to the initial assessment of patients with lower gastrointestinal symptoms: not FIT for purpose?
    Quyn AJ; Steele RJ; Digby J; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Fraser CG
    Ann Clin Biochem; 2018 Jan; 55(1):69-76. PubMed ID: 28661203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.
    Herrero JM; Vega P; Salve M; Bujanda L; Cubiella J
    BMC Gastroenterol; 2018 Oct; 18(1):155. PubMed ID: 30359225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer.
    Turvill JL; Turnock D; Cottingham D; Haritakis M; Jeffery L; Girdwood A; Hearfield T; Mitchell A; Keding A
    Br J Gen Pract; 2021 Aug; 71(709):e643-e651. PubMed ID: 33798091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
    Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
    Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
    Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
    BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.
    Westwood M; Lang S; Armstrong N; van Turenhout S; Cubiella J; Stirk L; Ramos IC; Luyendijk M; Zaim R; Kleijnen J; Fraser CG
    BMC Med; 2017 Oct; 15(1):189. PubMed ID: 29061126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
    Pin Vieito N; Zarraquiños S; Cubiella J
    World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
    Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
    Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
    Farrugia A; Widlak M; Evans C; Smith SC; Arasaradnam R
    Frontline Gastroenterol; 2020 Jan; 11(1):28-33. PubMed ID: 31885837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
    Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
    Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low faecal haemoglobin concentration potentially rules out significant colorectal disease.
    McDonald PJ; Digby J; Innes C; Strachan JA; Carey FA; Steele RJ; Fraser CG
    Colorectal Dis; 2013 Mar; 15(3):e151-9. PubMed ID: 23199241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
    Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
    Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
    Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
    J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population.
    Bailey JA; Ibrahim H; Bunce J; Chapman CJ; Morling JR; Simpson JA; Humes DJ; Banerjea A
    Tech Coloproctol; 2021 Oct; 25(10):1151-1154. PubMed ID: 34263362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
    Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
    Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
    BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study.
    Elias SG; Kok L; de Wit NJ; Witteman BJ; Goedhard JG; Romberg-Camps MJ; Muris JW; Moons KG
    BMC Med; 2016 Sep; 14(1):141. PubMed ID: 27666114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.